Marc O. Anderson

2.6k total citations · 1 hit paper
56 papers, 2.0k citations indexed

About

Marc O. Anderson is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Marc O. Anderson has authored 56 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Organic Chemistry. Recurrent topics in Marc O. Anderson's work include Ion Transport and Channel Regulation (18 papers), Ion channel regulation and function (10 papers) and Electrolyte and hormonal disorders (7 papers). Marc O. Anderson is often cited by papers focused on Ion Transport and Channel Regulation (18 papers), Ion channel regulation and function (10 papers) and Electrolyte and hormonal disorders (7 papers). Marc O. Anderson collaborates with scholars based in United States, United Kingdom and Türkiye. Marc O. Anderson's co-authors include A.S. Verkman, Marios C. Papadopoulos, Puay‐Wah Phuan, Lukmanee Tradtrantip, A. S. Verkman, Cristina Esteva‐Font, Scott Eagon, R. Kiplin Guy, Alexander J. Smith and Chenjuan Yao and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Chemical Physics and The Journal of Physiology.

In The Last Decade

Marc O. Anderson

54 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aquaporins: important but elusive drug targets

2014 450 citations A.S. Verkman, Marc O. Anderson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc O. Anderson United States	23	1.2k	411	324	177	140	56	2.0k
Puay‐Wah Phuan United States	28	1.1k 0.9×	469 1.1×	521 1.6×	82 0.5×	411 2.9×	52	2.4k
Laurent Désaubry France	30	1.8k 1.6×	611 1.5×	150 0.5×	419 2.4×	128 0.9×	90	3.2k
Anthony M. Treston United States	25	1.3k 1.1×	273 0.7×	288 0.9×	532 3.0×	78 0.6×	79	2.6k
Ganesha Rai United States	26	1.3k 1.1×	311 0.8×	104 0.3×	175 1.0×	54 0.4×	90	2.2k
Pavel A. Petukhov United States	29	1.2k 1.0×	801 1.9×	111 0.3×	250 1.4×	43 0.3×	88	2.3k
Manon Carré France	27	1.1k 0.9×	349 0.8×	193 0.6×	675 3.8×	86 0.6×	65	2.3k
Hirofumi Nakano Japan	26	1.6k 1.4×	434 1.1×	229 0.7×	637 3.6×	31 0.2×	140	3.1k
Salvador Harguindey Italy	21	1.5k 1.3×	154 0.4×	121 0.4×	393 2.2×	54 0.4×	47	2.3k
Sophie Martin France	31	1.3k 1.1×	149 0.4×	144 0.4×	306 1.7×	39 0.3×	82	2.5k
Fengtian Xue United States	27	738 0.6×	595 1.4×	46 0.1×	181 1.0×	163 1.2×	90	1.9k

Countries citing papers authored by Marc O. Anderson

Since Specialization

Citations

This map shows the geographic impact of Marc O. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc O. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc O. Anderson more than expected).

Fields of papers citing papers by Marc O. Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc O. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc O. Anderson. The network helps show where Marc O. Anderson may publish in the future.

Co-authorship network of co-authors of Marc O. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Marc O. Anderson. A scholar is included among the top collaborators of Marc O. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc O. Anderson. Marc O. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, Marc O., et al.. (2025). TMEM16A in gastrointestinal and vascular smooth muscle contractility. The Journal of Physiology.

Haggie, Peter M., et al.. (2024). High potency 3-carboxy-2-methylbenzofuran pendrin inhibitors as novel diuretics. European Journal of Medicinal Chemistry. 283. 117133–117133. 1 indexed citations

Haggie, Peter M., et al.. (2023). Selective isoxazolopyrimidine PAT1 (SLC26A6) inhibitors for therapy of intestinal disorders. RSC Medicinal Chemistry. 14(11). 2342–2347. 2 indexed citations

Çil, Onur, Marc O. Anderson, Lívia de Souza Gonçalves, et al.. (2023). Small molecule inhibitors of intestinal epithelial anion exchanger SLC26A3 (DRA) with a luminal, extracellular site of action. European Journal of Medicinal Chemistry. 249. 115149–115149. 9 indexed citations

Qiu, Jingjing, et al.. (2022). Plasmon-enhanced electrochemical oxidation of 4-(hydroxymethyl)benzoic acid. The Journal of Chemical Physics. 157(8). 81101–81101. 3 indexed citations

Galli, Lisa M., et al.. (2021). Determination of the membrane topology of PORCN, an O-acyl transferase that modifies Wnt signalling proteins. Open Biology. 11(6). 200400–200400. 9 indexed citations

Zhang, Linlin, et al.. (2021). Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds. Bioorganic & Medicinal Chemistry Letters. 41. 127990–127990. 2 indexed citations

Ferrera, Loretta, Luis J. V. Galietta, Onur Çil, et al.. (2017). Substituted 2-Acylaminocycloalkylthiophene-3-carboxylic Acid Arylamides as Inhibitors of the Calcium-Activated Chloride Channel Transmembrane Protein 16A (TMEM16A). Journal of Medicinal Chemistry. 60(11). 4626–4635. 38 indexed citations

Esteva‐Font, Cristina, Byung‐Ju Jin, Sujin Lee, et al.. (2016). Experimental Evaluation of Proposed Small-Molecule Inhibitors of Water Channel Aquaporin-1. Molecular Pharmacology. 89(6). 686–693. 25 indexed citations

10.

Kim, Yonjung, Marc O. Anderson, Jin‐Hong Park, et al.. (2015). Benzopyrimido-pyrrolo-oxazine-dione (R)-BPO-27 Inhibits CFTR Chloride Channel Gating by Competition with ATP. Molecular Pharmacology. 88(4). 689–696. 17 indexed citations

11.

Çil, Onur, Cristina Esteva‐Font, Tao Su, et al.. (2015). Salt-sparing diuretic action of a water-soluble urea analog inhibitor of urea transporters UT-A and UT-B in rats. Kidney International. 88(2). 311–320. 19 indexed citations

12.

Esteva‐Font, Cristina, Puay‐Wah Phuan, Sujin Lee, et al.. (2015). Structure-activity analysis of thiourea analogs as inhibitors of UT-A and UT-B urea transporters. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(5). 1075–1080. 15 indexed citations

13.

Valentine, Cathleen D., Marc O. Anderson, Feroz R. Papa, & Peter M. Haggie. (2013). X-Box Binding Protein 1 (XBP1s) Is a Critical Determinant of Pseudomonas aeruginosa Homoserine Lactone-Mediated Apoptosis. PLoS Pathogens. 9(8). e1003576–e1003576. 20 indexed citations

14.

Choy, Cindy J., et al.. (2013). Rationally Designed Sulfamides as Glutamate Carboxypeptidase II Inhibitors. Chemical Biology & Drug Design. 82(5). 612–619. 5 indexed citations

15.

Esteva‐Font, Cristina, Puay‐Wah Phuan, Marc O. Anderson, & A.S. Verkman. (2013). A Small Molecule Screen Identifies Selective Inhibitors of Urea Transporter UT-A. Chemistry & Biology. 20(10). 1235–1244. 39 indexed citations

16.

Berkman, Clifford E., et al.. (2011). N‐Substituted Glutamyl Sulfonamides as Inhibitors of Glutamate Carboxypeptidase II (GCP2). Chemical Biology & Drug Design. 77(4). 241–247. 18 indexed citations

17.

Li, Fusheng, et al.. (2009). Nordihydroguaiaretic acid inhibits transforming growth factor β type 1 receptor activity and downstream signaling. European Journal of Pharmacology. 616(1-3). 31–37. 10 indexed citations

18.

Wu, Lisa Y., et al.. (2007). Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen. Bioorganic & Medicinal Chemistry Letters. 18(1). 281–284. 12 indexed citations

19.

Anderson, Marc O., et al.. (2007). Substrate specificity of prostate-specific membrane antigen. Bioorganic & Medicinal Chemistry. 15(21). 6678–6686. 35 indexed citations

20.

Anderson, Marc O., et al.. (2005). A Convenient Procedure for Parallel Ester Hydrolysis.. ChemInform. 36(18). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact